JANE PAHUD: Open Payments
NPI 1487339990 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,960 in 63 payments from 13 companies in 2025. Trend: 2023 $301 · 2024 $8,954 · 2025 $2,960
Food & beverage: $1,637Travel & lodging: $1,323
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $1,736 |
| UCB, Inc. | 7 | $213 |
| Lundbeck LLC | 3 | $197 |
| PFIZER INC. | 10 | $179 |
| ABBVIE INC. | 10 | $168 |
| ARGENX US, INC. | 9 | $165 |
| Merz Pharmaceuticals, LLC | 2 | $61 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Alexion Pharmaceuticals, Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
Products named: INFINITY, VYEPTI, PROCLAIM, VYVGART HYTRULO, PANZYGA, QULIPTA, Fintepla, Briviact.
Industry payments across CO — which companies pay providers there.
